文献速递肾癌与肾肿瘤

肾细胞癌干预前肾实质体积替代:预测因素与功能影响

Parenchymal Volume Replacement by Renal Cell Carcinoma Prior to Intervention: Predictive Factors and Functional Implications.
PubMed 文献 · Urology · 2021-10-02

回顾性分析146例部分肾切除和136例根治性肾切除患者的术前影像与核素肾扫描,以对侧肾为对照估算肿瘤替代肾实质体积百分比(PVR)。根治性肾切除患者中位PVR为15%,四分之一患者PVR≥27%,且PVR与同侧术前肾功能呈负相关;部分肾切除患者PVR可忽略。肿瘤大小、分期和内生性是与PVR相关的因素。

要点

  • 根治性肾切除患者术前PVR中位15%,四分之一≥27%,可加重既存肾功能不全。
  • 部分肾切除患者PVR可忽略,同侧与对侧肾实质体积几乎相同(179/180cc)。
  • 肿瘤大小、分期和内生性特征与根治性肾切除患者的PVR独立相关。

核心结论

  • 根治性肾切除患者中肿瘤替代正常肾实质常见且可导致术前肾功能不全,部分肾切除患者PVR可忽略。

研究设计与样本

  • 回顾性分析146例部分肾切除和136例根治性肾切除患者,均有术前核素肾扫描和影像显示单发肾细胞癌且对侧肾正常。
  • 通过术前轴位图像手工勾画测量各肾正常肾实质体积,以对侧肾为对照估算PVR百分比。

主要发现

  • 根治性肾切除患者中位PVR为15%,四分之一患者PVR≥27%。
  • 部分肾切除患者PVR可忽略,同侧与对侧术前肾实质体积中位分别为179cc和180cc。
  • PVR与同侧术前肾功能呈负相关(P<.01)。
  • 多变量分析显示肿瘤大小(P<.01)、分期(P=.03)和内生性(P=.03)与PVR相关。

临床怎么用

  • 根治性肾切除术前应评估PVR,尤其肿瘤较大、分期较高或内生性生长者,以识别既存肾功能不全风险。

局限性

  • 回顾性设计,仅纳入有术前核素肾扫描和影像的患者,PVR估算依赖对侧肾正常的假设。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze predictors, extent and functional implications associated with renal parenchymal volume replacement (PVR) by renal cell carcinoma (RCC) prior to intervention. This phenomenon is well-recognized yet not adequately studied, and, if severe, can influence management. MATERIALS AND METHODS: A retrospective review was performed of partial nephrectomy (PN) and radical nephrectomy (RN) patients with available preoperative nuclear-renal-scan and imaging demonstrating solitary RCC with normal contralateral kidney. Normal renal parenchymal volume of each kidney was measured by free-hand scripting from preoperative axial images. Primary endpoint was percent PVR which was estimated assuming that the contralateral-kidney serves as a control: PVR = (volume contralateral kidney - volume ipsilateral kidney) normalized by volume contralateral kidney. Multivariable linear-regression analysis assessed factors associated with preoperative PVR. Further analysis evaluated the functional effect of PVR prior to surgery. RESULTS: 146 PN and 136 RN patients with necessary studies were analyzed. For RN, the median PVR was 15% and a quarter of patients had PVR ≥27%. In contrast, PVR was negligible in PN patients for whom median preoperative parenchymal volumes were nearly identical in the ipsilateral/contralateral kidneys (179/180cc, respectively). PVR inversely correlated with preoperative renal function in the ipsilateral kidney (P <.01). Tumor-size (P <.01), stage (P = .03), and endophytic properties (P = .03) associated with PVR on multivariable-analysis. CONCLUSION: Our data suggest that substantial replacement of normal parenchyma by RCC occurs in many patients selected for RN and can contribute to preexisting renal-insufficiency. PVR prior to intervention is mainly driven by tumor characteristics in RN patients, but is negligible in most PN patients.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Palacios DA, Campbell RA, Yasuda Y, et al. Parenchymal Volume Replacement by Renal Cell Carcinoma Prior to Intervention: Predictive Factors and Functional Implications. Urology. 2021. PMID: 34606882. doi:10.1016/j.urology.2021.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。